Mana Kobayashi

All-case Japanese post-marketing surveillance of the real-world safety and efficacy of rituximab treatment in patients with refractory nephrotic syndrome

T. Ando, Mana Kobayashi, Yutaro Kageyama, 2021, Clinical and Experimental Nephrology.

Comparison of Sofosbuvir Plus Ribavirin Treatment with Pegylated Interferon Plus Ribavirin Treatment for Chronic Hepatitis C Genotype 2

M. Kudo, Y. Yano, Y. Hayashi, 2017, Digestive Diseases.

Efficacy and Safety of Sofosbuvir Plus Ribavirin Treatment for Patients with Chronic Hepatitis C Genotype 2

M. Kudo, Yasuhito Tanaka, Y. Yano, 2016, Digestive Diseases.